Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Neoplasms 3Depression 3Anxiety Disorders 3Skin Neoplasms 2Urinary Bladder Neoplasms 1Polycystic Ovary Syndrome 1Keratosis, Actinic 1Hand-Foot Skin Reaction (HFSR) 1Glioblastoma 1Breast Neoplasms 1Advanced Cancer 1

Interventions

pembrolizumab 23Nivolumab 22aldesleukin 21Cyclophosphamide 20Ipilimumab 17Interleukin-2 17fludarabine 15fludarabine phosphate 14cemiplimab 12Radiotherapy 7Fluorouracil 7Dacarbazine 6binimetinib 5Vemurafenib 5Temozolomide 5Surgical Procedures, Operative 5Sirolimus 5Radiation 5Biopsy 5Aminolevulinic Acid 5encorafenib 4dabrafenib 4Photochemotherapy 4Educational Status 4trametinib 3sonidegib 3montanide ISA 51 3avelumab 3Tacrolimus 3Sodium Chloride 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Skin Neoplasms × Niacin × Clear all
NCT05702398 2026-03-20

Pilot Trial of Supplemental Vitamin A and Nicotinamide

Rhode Island Hospital

Phase EARLY_PHASE1 Recruiting
30 enrolled
Dermatologic

Skin Neoplasms

NCT00619060 2016-03-10

Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers

University of Arizona

Phase 1 Completed
22 enrolled 5 charts
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡